Advances in diagnostic testing are poised to transform disease detection and patient monitoring. Phase Scientific launched a large-scale clinical study of its urine-based HPV test aimed at cervical cancer screening in China, coupling noninvasive diagnostics with AI-powered colposcopy, targeting greater accessibility. PacBio expanded its PureTarget carrier screening product suite, leveraging high-fidelity long-read sequencing to streamline assay workflows and address difficult-to-sequence genes, facilitating scalable genetic testing. Harvard-led researchers developed three-dimensional soft microbump electrodes to enhance neural interface elasticity, potentially improving brain-computer interfaces. These innovations collectively advance precision, accessibility, and efficiency in diagnostics.